PR94169

ZUG, Switzerland, Jan 20, 2022 /PRNewswire=KYODO JBN/ --

Medison [https://www.medisonpharma.com], a global pharma company focused on

providing access to highly innovative therapies to patients in international

markets (“Medison”), is proud to announce the joining of Victor Papamoniodis in

the newly created position of VP International Markets. Victor will be based in

Zug, Switzerland, Medison’s international headquarters.

Victor will head Medison's markets outside of Israel and will focus on scaling

up the company's presence across markets, while growing and nurturing

relationships with Medison’s global partners.

Prior to joining Medison, Victor held the position of VP International &

Emerging Markets at  Apellis Pharmaceuticals, Inc. Prior to that, he spent 9

years at Vertex Pharmaceuticals Incorporated as GM for Distributors & Expansion

Markets, responsible for multiple regions, including CEE, LATAM, Russia & MENA.

“I am delighted to join Medison’s global leadership at an exciting time of

rapid growth and expansion into new markets. Medison creates a real paradigm

shift in the pharma industry, positioning itself as the next-gen partner for

biotech companies who wish to access international markets and serve patients

in need,” said Victor Papamoniodis.

“Medison is set out to change patients’ lives in international markets,

bridging the unbearable access gap and making the most innovative therapies

accessible to patients,” said Meir Jakobsohn, Founder and CEO of Medison. “The

experience and capabilities that Victor brings will take our international

platform to the next level.”

“Adding Victor’s capabilities will accelerate Medison’s expansion into

additional markets and regions, building a true unified platform for the

benefit of partners and patients, globally,” added Gil Gurfinkel, VP Corporate

Development of Medison.

About Medison Pharma

Medison is a global pharma company focused on providing access to highly

innovative therapies to patients in international markets. Medison is the first

to create an international commercialization platform for highly innovative

therapies, helping to save and improve lives by making the best available novel

treatments accessible to patients in international markets. Medison has a track

record of multi-territorial partnerships with leading pharmaceutical and

biotech companies seeking to expand their global reach. To learn more visit

www.medisonpharma.com.

Photo - https://mma.prnewswire.com/media/1729991/Medison_Pharma_VP.jpg

Logo - https://mma.prnewswire.com/media/1527224/MEDISON_Logo.jpg

Medison Contact

Maya Nix

Corporate Communications Lead

mayan@medison.co.il

+972-3-925-0260

Source: Medison Pharma